NCT01125787 - Clinical Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia With a Combination of Bendamustine and Ofatumumab | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

August 31, 2010

Study Completion Date

April 30, 2011

Conditions

Chronic Lymphocytic Leukemia (CLL)

Interventions

DRUG

ofatumumab + bendamustine

Loading dose of ofatumumab at 300mg IV with subsequent doses at 100mg IV on D1 of all cycles (maximum of 6 cycles) in combination with bendamustine 90mg/m2 on day 2 of all cycles. Neulasta 6mg SQ will also be given on day 8 of cycle 1 only.

Trial Locations (2)

32610

University of Florida, Gainesville

89135

Nevada Cancer Institute, Las Vegas